Latest filing published 26 Feb 2013 for Navidea Biopharmaceuticals, INC..
Insider track record
No signal scores available.
Jess Jones: trading record in brief
Jess Jones discloses dealings in Navidea Biopharmaceuticals, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 10 April 2012 and the latest from 21 February 2013.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 26 February 2013: a share grant, in Navidea Biopharmaceuticals, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jess Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,250 shares0Common StockSEC:0001225208-13-005554:0
- 17,000 shares0Common StockSEC:0001225208-12-009635:0
2 of 2 declarations